Skip to content
2000
image of Stem Cells Derived From Human Deciduous Exfoliated Teeth Ameliorate Adriamycin-Induced Nephropathy In Rats By Modulating The Th17/Treg Balance

Abstract

Background

Idiopathic Nephrotic Syndrome (INS) is a common kidney disease in children, and the main clinical manifestations are hypoproteinaemia, proteinuria, hyperlipidaemia, and oedema. Mesenchymal Stem Cells (MSCs) are involved in tissue repair, protection against fibrosis, and immune modulation but have rarely been studied in INS.

Objective

This study aimed to explore the therapeutic potential of stem cells derived from human exfoliated deciduous teeth (SHEDs) in INS using an adriamycin-induced nephropathy (AN) rat model.

Methods

AN was induced in Sprague‒Dawley rats, and SHEDs were transplanted the tail vein in single (SHED-s) and multidose (SHED-m) regimens. Cell migration assays were used to track the SHED distribution. Weight, urine protein, and serum biochemical assays were also performed. HE and Masson staining were used to observe glomerular and tubular damage, as well as the degree of fibrosis. Immunohistochemistry was used to label T lymphocytes and podocytes, and structural changes in podocytes were observed by electron microscopy. ELISA was used to measure the levels of inflammatory factors. Flow cytometry was used to analyse the balance of Th17 cells and Tregs. The mRNA expression of Th17- and Treg-associated cytokines and specific transcription factors was examined by RT‒PCR.

Results

SHEDs directly migrated to damaged tissues, suggesting a targeted therapeutic effect. SHED transplantation significantly reduced proteinuria and reversed biochemical abnormalities in rats with AN. Both single and multidose SHED treatments could inhibit glomerular and tubular damage and delay the progression of fibrosis caused by adriamycin. SHEDs exerted a protective effect on podocytes. Additionally, this treatment inhibited inflammatory responses and corrected immune imbalances, as evidenced by decreased T lymphocyte infiltration, reduced serum levels of IL-6, TNF-a, and IL-1β, and modulation of the Th17/Treg balance.

Conclusion

In the AN rat model, SHED partly suppressed the development of inflammation and alleviated kidney injury, and immune regulation may be the underlying mechanism.

Loading

Article metrics loading...

/content/journals/cscr/10.2174/011574888X336035241209065513
2024-12-20
2025-01-22
Loading full text...

Full text loading...

References

  1. Wang C. Greenbaum L.A. Nephrotic Syndrome. Pediatr. Clin. North Am. 2019 66 1 73 85 10.1016/j.pcl.2018.08.006 30454752
    [Google Scholar]
  2. Zabala Ramirez M.J. Stein E.J. Jain K. Nephrotic Syndrome for the Internist. Med. Clin. North Am. 2023 107 4 727 737 10.1016/j.mcna.2023.03.006 37258010
    [Google Scholar]
  3. Zhang F. Liu J. Yu J. Sun W. Wang Y. Fan T. Sun Y. Han X. Effect of Nephropathy Prescription I on the Expression of Angptl3 and Podocyte-Associated Protein in Mice with Adriamycin-Induced Nephropathy. Evid. Based Complement. Alternat. Med. 2022 2022 1 13 10.1155/2022/9921679 38149181
    [Google Scholar]
  4. Trautmann A. Vivarelli M. Samuel S. Gipson D. Sinha A. Schaefer F. Hui N.K. Boyer O. Saleem M.A. Feltran L. Müller-Deile J. Becker J.U. Cano F. Xu H. Lim Y.N. Smoyer W. Anochie I. Nakanishi K. Hodson E. Haffner D. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr. Nephrol. 2020 35 8 1529 1561 10.1007/s00467‑020‑04519‑1 32382828
    [Google Scholar]
  5. Hampson K.J. Gay M.L. Band M.E. Pediatric Nephrotic Syndrome: Pharmacologic and Nutrition Management. Nutr. Clin. Pract. 2021 36 2 331 343 10.1002/ncp.10622 33469930
    [Google Scholar]
  6. Ahn W. Bomback A.S. Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020. Am. J. Kidney Dis. 2020 75 6 955 964 10.1053/j.ajkd.2019.12.019 32331832
    [Google Scholar]
  7. Shuai L. Cheng Q. Shen T. Yi Z. Wu X. CTLA4-Ig Abatacept Ameliorates Proteinuria by Regulating Circulating Treg/IL-17 in Adriamycin-Induced Nephropathy Rats. BioMed Res. Int. 2020 2020 1 9 10.1155/2020/2347827 32420329
    [Google Scholar]
  8. Le Berre L. Bruneau S. Naulet J. Renaudin K. Buzelin F.C.O.M.B.I.N.I.N.G.C.E.D.I.L.L.A. Usal C. Smit H. Condamine T. Soulillou J.P. Dantal J. Induction of T regulatory cells attenuates idiopathic nephrotic syndrome. J. Am. Soc. Nephrol. 2009 20 1 57 67 10.1681/ASN.2007111244 19020006
    [Google Scholar]
  9. Ma L. Zhang H. Hu K. Lv G. Fu Y. Ayana D.A. Zhao P. Jiang Y. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients. BMC Immunol. 2015 16 1 56 10.1186/s12865‑015‑0118‑8 26400627
    [Google Scholar]
  10. Xu Y. Lin H. Zheng W. Ye X. Yu L. Zhuang J. Yang Q. Wang D. Matrine ameliorates adriamycin-induced nephropathy in rats by enhancing renal function and modulating Th17/Treg balance. Eur. J. Pharmacol. 2016 791 491 501 10.1016/j.ejphar.2016.09.022 27640745
    [Google Scholar]
  11. Castro-Manrreza M.E. Montesinos J.J. Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications. J. Immunol. Res. 2015 2015 1 20 10.1155/2015/394917 25961059
    [Google Scholar]
  12. Luo C. Luo F. Man X. liu X. Zhao L. Che L. Zhang W. Guo J. Cai S. Wang D. Xu Y. Mesenchymal Stem Cells Attenuate Sepsis-associated Acute Kidney Injury by Changing the Balance of Th17 cells/Tregs via Gal-9/Tim-3. Curr. Stem Cell Res. Ther. 2023 18 4 540 550 10.2174/1574888X17666220511151343 35546754
    [Google Scholar]
  13. Aslam R. Hussain A. Cheng K. Kumar V. Malhotra A. Gupta S. Singhal P.C. Transplantation of mesenchymal stem cells preserves podocyte homeostasis through modulation of parietal epithelial cell activation in adriamycin-induced mouse kidney injury model. Histol. Histopathol. 2020 35 12 1483 1492 33124682
    [Google Scholar]
  14. Suchánek J. Víšek B. Soukup T. El-Din Mohamed S.K. Ivančaková R. Mokrý J. Aboul-Ezz E.H.A. Omran A. Stem cells from human exfoliated deciduous teeth--isolation, long term cultivation and phenotypical analysis. Acta Med. (Hradec Kralove) 2010 53 2 93 99 10.14712/18059694.2016.66 20672745
    [Google Scholar]
  15. Dai Y.Y. Ni S.Y. Ma K. Ma Y.S. Wang Z.S. Zhao X.L. Stem cells from human exfoliated deciduous teeth correct the immune imbalance of allergic rhinitis via Treg cells in vivo and in vitro. Stem Cell Res. Ther. 2019 10 1 39 10.1186/s13287‑019‑1134‑z 30670101
    [Google Scholar]
  16. Yang R. Zhu X. Wang J. Wan F. Zhang H. Lin Y. Tang X. Zhu B. Bone marrow mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis in rat models. BMC Nephrol. 2018 19 1 335 10.1186/s12882‑018‑1137‑5 30466397
    [Google Scholar]
  17. Ma H. Sun L. Zhang X. Wu Y. Xu Y. Human umbilical mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis. Am. J. Med. Sci. 2013 346 6 486 493 10.1097/MAJ.0b013e3182831777 23514668
    [Google Scholar]
  18. Kim H.S. Lee J.S. Lee H.K. Park E.J. Jeon H.W. Kang Y.J. Lee T.Y. Kim K.S. Bae S.C. Park J.H. Han S.B. Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy. Immune Netw. 2019 19 5 e36 10.4110/in.2019.19.e36 31720047
    [Google Scholar]
  19. Ullah M. Liu D.D. Thakor A.S. Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement. iScience 2019 15 421 438 10.1016/j.isci.2019.05.004 31121468
    [Google Scholar]
  20. Magnasco A. Corselli M. Bertelli R. Ibatici A. Peresi M. Gaggero G. Cappiello V. Chiavarina B. Mattioli G. Gusmano R. Ravetti J.L. Frassoni F. Ghiggeri G.M. Mesenchymal stem cells protective effect in adriamycin model of nephropathy. Cell Transplant. 2008 17 10-11 1157 1167 10.3727/096368908787236567 19181210
    [Google Scholar]
  21. Zhong F. Wang W. Lee K. He J.C. Chen N. Role of C/EBP-α in Adriamycin-induced podocyte injury. Sci. Rep. 2016 6 1 33520 10.1038/srep33520 27644413
    [Google Scholar]
  22. Jin J. Shi Y. Gong J. Zhao L. Li Y. He Q. Huang H. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res. Ther. 2019 10 1 95 10.1186/s13287‑019‑1177‑1 30876481
    [Google Scholar]
  23. Puissant B. Barreau C. Bourin P. Clavel C. Corre J. Bousquet C. Taureau C. Cousin B. Abbal M. Laharrague P. Penicaud L. Casteilla L. Blancher A. Immunomodulatory effect of human adipose tissue‐derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br. J. Haematol. 2005 129 1 118 129 10.1111/j.1365‑2141.2005.05409.x 15801964
    [Google Scholar]
  24. Raphael I. Nalawade S. Eagar T.N. Forsthuber T.G. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 2015 74 1 5 17 10.1016/j.cyto.2014.09.011 25458968
    [Google Scholar]
  25. Liu Y. Su L. Lin Q. Han Y. You P. Fan Q. Induction of C-Mip by IL-17 Plays an Important Role in Adriamycin-Induced Podocyte Damage. Cell. Physiol. Biochem. 2015 36 4 1274 1290 10.1159/000430296 26160339
    [Google Scholar]
  26. Lin X. You Y. Wang J. Qin Y. Huang P. Yang F. MicroRNA-155 deficiency promotes nephrin acetylation and attenuates renal damage in hyperglycemia-induced nephropathy. Inflammation 2015 38 2 546 554 10.1007/s10753‑014‑9961‑7 24969676
    [Google Scholar]
  27. Li Y. Liu H. Yan H. Xiong J. Research advances on targeted-Treg therapies on immune-mediated kidney diseases. Autoimmun. Rev. 2023 22 2 103257 10.1016/j.autrev.2022.103257 36563769
    [Google Scholar]
  28. Kim M.G. Koo T.Y. Yan J.J. Lee E. Han K.H. Jeong J.C. Ro H. Kim B.S. Jo S.K. Oh K.H. Surh C.D. Ahn C. Yang J. IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. J. Am. Soc. Nephrol. 2013 24 10 1529 1536 10.1681/ASN.2012080784 23833258
    [Google Scholar]
  29. Motavalli R. Etemadi J. Soltani-Zangbar M.S. Ardalan M.R. Kahroba H. Roshangar L. Nouri M. Aghebati-Maleki L. Khiavi F.M. Abediazar S. Mehdizadeh A. Hojjat-Farsangi M. Mahmoodpoor A. Kafil H.S. Zolfaghari M. Ahmadian Heris J. Yousefi M. Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy. Cytokine 2021 141 155452 10.1016/j.cyto.2021.155452 33571932
    [Google Scholar]
  30. Genç D. Zibandeh N. Nain E. Gökalp M. Özen A.O. Göker M.K. Akkoç T. Dental follicle mesenchymal stem cells down‐regulate Th2‐mediated immune response in asthmatic patients mononuclear cells. Clin. Exp. Allergy 2018 48 6 663 678 10.1111/cea.13126 29498435
    [Google Scholar]
  31. Maier T. Güell M. Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 2009 583 24 3966 3973 10.1016/j.febslet.2009.10.036 19850042
    [Google Scholar]
  32. Večerić-Haler Ž. Cerar A. Perše M. (Mesenchymal) Stem Cell-Based Therapy in Cisplatin-Induced Acute Kidney Injury Animal Model: Risk of Immunogenicity and Tumorigenicity. Stem Cells Int. 2017 2017 1 17 10.1155/2017/7304643 29379525
    [Google Scholar]
/content/journals/cscr/10.2174/011574888X336035241209065513
Loading
/content/journals/cscr/10.2174/011574888X336035241209065513
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test